More Therapeutic Area Expertise

Navigating the challenges of novel therapeutic development is complex - apply our broad therapy area knowledge-base to achieve success


Veristat has partnered with clients to bring drugs and biologics to market in nearly every therapy area. While the majority of our ongoing studies are for therapies to treat Cancers, Rare Diseases, Neurological Disorders, Cardiovascular Diseases, and Infectious Diseases, our company and experts bring a vast array of therapeutic expertise. We have a diverse portfolio of experience running hundreds of studies outside of our core therapy areas as well.

Knowledge Spanning Novel, Complex, and Rare Therapy Areas 

Our teams support amazing, cutting-edge, life-enhancing. and life-saving therapies that range from chronic and debilitating autoimmune diseases such as Irritable Bowel Syndrome to pediatric gene therapies for treating genetic disorders to live-saving anti-rejection drugs following kidney transplantation. We have the right expertise and therapeutic understanding and creative know-how to help you design, build, and run your clinical development program in any therapeutic area.


Scientific Expertise Across Many Therapy Areas


The Knowledge and Experience to Navigate the Rarest and Most Complex Therapies

Our scientific-minded experts have mastered the complexities of therapeutic development enabling sponsors to succeed in extending and saving lives. 

Veristat delivers the right expertise for clinical program planning, trial conduct, navigating the regulatory approval process, and ensuring post-approval safety surveillance in the following therapy areas:

Wide Range of Therapeutic Areas
Cardiology/Vascular Disease
   Hepatology    Orthopedics
CNS/Neurological Disease
   Immunology    Pain Management
Infectious Diseases
Endocrine/Metabolic Disorders
   Nephrology    Rheumotology
   Gastroenterology    Obstetrics/Gynecology    Genetic Disorders
   Women's Health   


Learn More with These Resources

Conference Presentation

The Role of Natural History Studies in Ultra-Rare Disease ...

Get the Presentation that was given at the Orphan Drug Congress Europe 2021. Completing a natural history study in conjunction with an interventional study for ...


Case Study

First Gene Therapy Approved in Europe

Veristat was brought in to create and manage a full development program for a gene therapy for a very rare inherited disorder. The work involved charting the course in ...


Published Article

Overcoming Challenges in Orphan Drug Development

While there is no ‘out-of-the-box’ roadmap for orphan drug development, through a toolkit of innovative solutions, we can address the unique aspects of clinical development ...

Request A Proposal